19 November 2026
by Ferdous Al-Faruque

FDA finalizes guidance on transferring 510(k) ownership

FDA_HQ4_260416_ALF.png
FDA headquarters in Silver Spring, MD. (credit: Ferdous Al-Faruque)

The US Food and Drug Administration (FDA) has finalized a guidance that outlines the responsibilities of owners of 510(k) clearances when products are sold or transferred between companies. The final document significantly shortens certain sections, while adding new questions and answers.

FDA issued the draft version of the guidance in a question-and-answer format last year. It stated that when a 510(k) clearance for a specific device is sold or transferred from one person to another, the new 510(k) holder must list their device in the FDA Unified Registration and Listing System (FURLS)/ Device Registration and Listing Module (DRLM) within 30 days of the transfer. (RELATED: FDA issues guidance on transferring 510(k) ownership, Regulatory Focus 9 June 2025)

"When listing, if the device is not significantly changed or modified in design, components, method of manufacture, or intended use, the new 510(k) holder must enter the original FDA-assigned premarket submission number unless submitting a new 510(k), in which case the new 510(k) holder would supply the new FDA-assigned premarket submission number, in FDA’s electronic device registration and listing system," said FDA. "If the new 510(k) holder has significantly changed or modified the device in design, components, method of manufacture, or intended use, the new 510(k) holder must generally submit a new 510(k), and, when listing following clearance of the new 510(k), would enter the new FDA-assigned premarket submission number in FDA’s electronic device registration and listing system.

"When a 510(k) clearance for a specific device is sold or transferred from one person to another, the labeler must submit an update to the information required by 21 CFR 830.310 by using the Global Unique Device Identification Database (GUDID) if such information (for example, the name of the labeler) has changed," the agency added. "If you fail to register, list, update GUDID information, or submit a marketing application when required, your device may be considered adulterated and/or misbranded."

While the draft version included a lengthy section on the background and scope of the guidance, the final version is significantly shortened to state that the guidance applies to both the previous and the new 510(k) holder after the cleared device has been sold or transferred from one person to another.

The final version also includes new questions that appear to have been drawn from the background section of the draft version. It includes questions such as who needs to register and list the transferred product.

"An owner or operator of an establishment who is engaged in the manufacture, preparation, propagation, compounding, assembly, or processing of a device intended for human use is generally required to register the establishment and submit listing information for all devices in commercial distribution," said FDA.

Compared to the draft version, the final guidance makes no distinction between domestic and foreign manufacturers of 510(k) products marketed in the US and clarifies when a manufacturer must submit a 510(k). Again, drawing on the background section of the draft version, FDA noted that manufacturers are generally required to submit their 510(k)s at least 90 days before the proposed distribution date, whether for the first time or when an already marketed product is undergoing a significant change.

The final version also addresses the listing requirements for new 510(k) holders. The agency noted that 510(k) holders who are required to list their products must do so in FDA’s electronic device registration and listing system, which assigns a unique listing number.

FDA also addresses questions such as when a new 510(k) holder should register and list their product, which cleared 510(k) premarket notification submission number the new 510(k) holder must enter in FDA’s listing system, and whether a device can have simultaneous 510(k) holders; to which the simple answer is no.

"FDA considers there to be a single '510(k) holder' (e.g., an individual, partnership, corporation, association) for a device at a time," said FDA. "Having one 510(k) holder per device, among other things, helps to ensure compliance with applicable legal requirements, allows for appropriate tracking of signals and adverse events associated with devices, and facilitates communication between sponsors and FDA."

However, FDA stated that it understands there may be complicated business arrangements. The agency said that entities that are required to list a cleared device, such as contract manufacturers, contract sterilizers, repackagers, and relabelers, must use the FDA-assigned premarket submission number for the cleared 510(k) to list their device.

Final guidance